| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
|
Larivière, Ynke
|
|
|
24 |
7 |
p. 746-759
|
artikel
|
| 2 |
A measles outbreak in a school
|
Bagcchi, Sanjeet
|
|
|
24 |
7 |
p. 686
|
artikel
|
| 3 |
A step forward in the journey towards hookworm vaccines
|
Keiser, Jennifer
|
|
|
24 |
7 |
p. 673-674
|
artikel
|
| 4 |
A tribute to the elimination of leprosy
|
Das, Manjulika
|
|
|
24 |
7 |
p. 684
|
artikel
|
| 5 |
Avian influenza in cattle in the USA
|
Burki, Talha
|
|
|
24 |
7 |
p. e424-e425
|
artikel
|
| 6 |
Barbara Elizabeth Murray
|
Bagcchi, Sanjeet
|
|
|
24 |
7 |
p. 682
|
artikel
|
| 7 |
Can another infected blood scandal be averted?
|
The Lancet Infectious Diseases,
|
|
|
24 |
7 |
p. 665
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2024; published online April 3. https://doi.org/10.1016/S1473-3099(24)00142-7
|
|
|
|
24 |
7 |
p. e419
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2024; published online April 30. https://doi.org/10.1016/S1473-3099(24)00215-9
|
|
|
|
24 |
7 |
p. e419
|
artikel
|
| 10 |
Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study
|
Ylade, Michelle
|
|
|
24 |
7 |
p. 737-745
|
artikel
|
| 11 |
Emergence of Oropouche fever in Latin America: a narrative review
|
Wesselmann, Konrad M
|
|
|
24 |
7 |
p. e439-e452
|
artikel
|
| 12 |
Global incidence and mortality of severe fungal disease
|
Denning, David W
|
|
|
24 |
7 |
p. e428-e438
|
artikel
|
| 13 |
Global progress report on neglected tropical diseases
|
Jesudason, Timothy
|
|
|
24 |
7 |
p. e420
|
artikel
|
| 14 |
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
|
|
|
|
24 |
7 |
p. 698-725
|
artikel
|
| 15 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
24 |
7 |
p. e426
|
artikel
|
| 16 |
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial
|
Dixit, Avika
|
|
|
24 |
7 |
p. 687-697
|
artikel
|
| 17 |
Listeria monocytogenes: a rare, deadly cause of peritonitis
|
Gori, Maria
|
|
|
24 |
7 |
p. 676-677
|
artikel
|
| 18 |
Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases
|
Blanchard, Florian
|
|
|
24 |
7 |
p. 783-792
|
artikel
|
| 19 |
Managing loss during the COVID-9 pandemic
|
Dunsmuir, Henrietta
|
|
|
24 |
7 |
p. 683
|
artikel
|
| 20 |
Mycobacterium tuberculosis transmission: the importance of precision
|
Dinkele, Ryan
|
|
|
24 |
7 |
p. 679-681
|
artikel
|
| 21 |
New project to tackle visceral leishmaniasis in Kenya
|
Bagcchi, Sanjeet
|
|
|
24 |
7 |
p. e422
|
artikel
|
| 22 |
Nigeria leads pentavalent meningitis vaccine rollout
|
Boisson-Walsh, Alix
|
|
|
24 |
7 |
p. e421
|
artikel
|
| 23 |
Nipah virus disease: what can we do to improve patient care?
|
Hassan, Md Zakiul
|
|
|
24 |
7 |
p. e463-e471
|
artikel
|
| 24 |
Persistent SARS-CoV-2 infection: significance and implications
|
Machkovech, Heather M
|
|
|
24 |
7 |
p. e453-e462
|
artikel
|
| 25 |
Post-tuberculosis lung disease: is there a light at the end of tunnel?
|
Chakaya, Jeremiah
|
|
|
24 |
7 |
p. 677-679
|
artikel
|
| 26 |
Presence of Andes orthohantavirus in human body fluids
|
Markotić, Alemka
|
|
|
24 |
7 |
p. 674-676
|
artikel
|
| 27 |
Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis
|
Stuck, Logan
|
|
|
24 |
7 |
p. 726-736
|
artikel
|
| 28 |
Readiness in preventing filovirus epidemics by use of the marketed vaccines against Zaire Ebola virus disease as prototypes
|
Agnandji, Selidji T
|
|
|
24 |
7 |
p. 671-673
|
artikel
|
| 29 |
Research in brief
|
Venkatesan, Priya
|
|
|
24 |
7 |
p. e427
|
artikel
|
| 30 |
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial
|
Zinsou, Jeannot F
|
|
|
24 |
7 |
p. 760-774
|
artikel
|
| 31 |
Single dose of Dengvaxia vaccine: is it a cause for alarm?
|
Buerano, Corazon C
|
|
|
24 |
7 |
p. 670-671
|
artikel
|
| 32 |
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
|
de Lusignan, Simon
|
|
|
24 |
7 |
p. e417-e418
|
artikel
|
| 33 |
South Africa takes on drug-resistant tuberculosis
|
Adepoju, Paul
|
|
|
24 |
7 |
p. e423
|
artikel
|
| 34 |
Tetanus occurrence in a man with diabetes and neuropathy
|
Hasegawa, Shinya
|
|
|
24 |
7 |
p. e472
|
artikel
|
| 35 |
The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19 vaccination in children
|
Li, Si-Min
|
|
|
24 |
7 |
p. 666-667
|
artikel
|
| 36 |
The hidden threat of subclinical tuberculosis
|
Wei, Xiaolin
|
|
|
24 |
7 |
p. 669-670
|
artikel
|
| 37 |
The inequity in reproductive health in Brazil
|
Burki, Talha
|
|
|
24 |
7 |
p. 685
|
artikel
|
| 38 |
Towards improving the quality and usefulness of GBD tuberculosis estimates
|
White, Richard G
|
|
|
24 |
7 |
p. 667-668
|
artikel
|
| 39 |
Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study
|
Ferrés, Marcela
|
|
|
24 |
7 |
p. 775-782
|
artikel
|
| 40 |
Virological characteristics of the SARS-CoV-2 KP.2 variant
|
Kaku, Yu
|
|
|
24 |
7 |
p. e416
|
artikel
|
Tijdschrift beschrijving